文献速递腹部技术与安全US

ACR超声肝脏报告与数据系统:一年期多中心临床性能评估

ACR Ultrasound Liver Reporting and Data System: Multicenter Assessment of Clinical Performance at One Year.
PubMed 文献 · J Am Coll Radiol · 2019-06-04

这项回顾性多中心研究评估了ACR超声肝脏报告与数据系统(US LI-RADS)在高危人群中检测肝细胞癌的临床性能,纳入美国五个中心2050例患者。约90%的筛查结果为阴性,5%为亚阈值,5%为阳性;在349例有确认性检查的患者中,敏感度为82.4%,特异度为74.2%,阳性预测值为35.3%,阴性预测值为96.1%。作者认为US LI-RADS强调了敏感度和阴性预测值这两个筛查试验的关键特征。

要点

  • US LI-RADS观察分类中US-1(阴性)占90.4%,US-2(亚阈值)占4.6%,US-3(阳性)占4.9%。
  • 可视化评分A(无或轻微限制)占76.8%,B(中度限制)占18.9%,C(重度限制)占4.2%。
  • 在有确认性检查的349例患者中,US LI-RADS敏感度82.4%、特异度74.2%、阳性预测值35.3%、阴性预测值96.1%。

核心结论

  • 约90%的US LI-RADS筛查检查为阴性,5%为亚阈值,5%为阳性;可视化评分在绝大多数(>95%)检查中达到诊断可接受水平;US LI-RADS强调了敏感度和阴性预测值这两个筛查试验的关键特征。

研究设计与样本

  • 回顾性多中心研究,纳入美国五个中心2050例肝细胞癌高危患者(1078例男性、972例女性,平均年龄57.7岁),于2017年1月至2018年2月接受筛查肝脏超声,US LI-RADS观察分类和可视化评分基于临床常规分配,回顾性查阅超声报告和患者记录并记录随访影像和/或病理报告,采用描述性统计和多变量逻辑回归分析临床及阅片者预测因素与可视化受限的关系,在具备确认性检查的患者亚组中计算诊断性能。

诊断标准与关键数值

  • US LI-RADS观察分类:US-1(阴性)占90.4%(n=1854),US-2(亚阈值)占4.6%(n=95),US-3(阳性)占4.9%(n=101);可视化评分:A(无或轻微限制)占76.8%(n=1575),B(中度限制)占18.9%(n=388),C(重度限制)占4.2%(n=87);在349例(17.0%)有确认性检查(多期增强CT或MRI n=331或组织病理学 n=18)的患者中,US LI-RADS敏感度82.4%、特异度74.2%、阳性预测值35.3%、阴性预测值96.1%。

临床应用与阅片要点

  • 筛查报告中应按US LI-RADS分配观察分类(US-1阴性、US-2亚阈值、US-3阳性)并记录可视化评分A/B/C,以反映检查的可诊断性;作者指出US LI-RADS强调了敏感度和阴性预测值,这是筛查试验的关键特征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to evaluate the clinical performance of the ACR's Ultrasound Liver Reporting and Data System (US LI-RADS™) for detecting hepatocellular carcinoma (HCC) in patients at high risk for HCC.

METHODS: In this retrospective, multicenter study, 2,050 patients at high risk for HCC (1,078 men and 972 women; mean age, 57.7 years) at five sites in the United States had undergone screening liver ultrasound from January 2017 to February 2018, and US LI-RADS observation categories and visualization scores were assigned on a clinical basis. Ultrasound reports and patient records were retrospectively reviewed and follow-up imaging studies and/or pathologic reports recorded. Descriptive statistics were generated, and multivariate logistic regression analysis was used to analyze the relationship of clinical and reader-based predictors of limited visualization. Diagnostic performance data were calculated in the subset of patients with confirmatory testing.

RESULTS: The most common indications for HCC screening were cirrhosis (n = 1,054 [51.4%]), noncirrhotic hepatitis B virus infection (n = 555 [27.1%]), and noncirrhotic hepatitis C virus infection (n = 234 [11.4%]). US LI-RADS observation categories assigned were US-1 (negative) in 90.4% (n = 1,854), US-2 (subthreshold) in 4.6% (n = 95), and US-3 (positive) in 4.9% (n = 101). Visualization scores were A (no or minimal limitations) in 76.8% (n = 1,575), B (moderate limitations) in 18.9% (n = 388), and C (severe limitations) in 4.2% (n = 87). Confirmatory tests, including multiphase contrast-enhanced CT or MRI (n = 331) or histopathology (n = 18), were available for 349 patients (17.0%). The sensitivity of US LI-RADS in this subset of patients was 82.4%, specificity was 74.2%, positive predictive value was 35.3%, and negative predictive value was 96.1%.

CONCLUSIONS: Approximately 90% of US LI-RADS screening examinations were negative, 5% subthreshold, and 5% positive. Visualization scores were diagnostically acceptable in the vast majority (>95%) of examinations. US LI-RADS emphasized sensitivity and negative predictive value, which are key characteristics of a screening test.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Millet JD, Kamaya A, Choi HH, et al. ACR Ultrasound Liver Reporting and Data System: Multicenter Assessment of Clinical Performance at One Year. J Am Coll Radiol. 2019. PMID: 31173745. doi:10.1016/j.jacr.2019.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。